SYNOTROL 800MG TABLET

Product Description

SYNOTROL 800MG TABLET
(Sevelamer Carbonate Tablets 800 mg)

Product Description:

SYNOTROL 800MG TABLET contains Sevelamer Carbonate 800 mg, a non-calcium, non-metal-based phosphate binder widely used in the management of hyperphosphatemia in patients with chronic kidney disease (CKD) undergoing dialysis. SYNOTROL effectively controls serum phosphate levels without increasing calcium load, making it a preferred choice in renal care protocols.

Specially manufactured under GMP-certified facilities, SYNOTROL 800MG is ideal for pharma distributors, hospital suppliers, retailers, and bulk medicine buyers seeking a reliable solution for renal therapeutics.

Key Benefits:

• Controls elevated phosphate levels in dialysis patients

• Reduces risk of vascular calcification

• Well-tolerated with minimal gastrointestinal side effects

• Suitable for long-term phosphate management in CKD

Usage/Application:
Recommended for hyperphosphatemia in end-stage renal disease (ESRD). Administered orally with meals as directed by a healthcare professional.

Why Choose SYNOTROL 800MG?

• High-quality formulation of Sevelamer Carbonate

• Competitive pricing for bulk supply and tenders

• Backed by stringent quality control standards

• Ideal for nephrology clinics, dialysis centers, and government supply contracts

For bulk orders, distributor tie-ups, or PCD franchise inquiries, get in touch today and strengthen your renal care product line with SYNOTROL 800MG.